Computational approaches for modeling GPCR dimerization

Current Pharmaceutical Biotechnology

Volumn 15, Issue 10, 2014, Pages 996-1006

  Meng, Xuan Yu ^a   Mezei, Mihaly ^b   Cui, Meng ^c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Brownian dynamics simulations; Coarse grained MD simulations; Computer modeling; Membrane protein dimerization; Molecular dynamics simulations; Protein docking

Indexed keywords

ADENOSINE A2A RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; HISTAMINE H1 RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MEMBRANE PROTEIN; NEUROTENSIN RECEPTOR; OPSIN; RHODOPSIN; THROMBOXANE A2 RECEPTOR; THYROTROPIN RECEPTOR;

ALGORITHM; ARTICLE; BIOINFORMATICS; COMPUTER MODEL; CRYSTAL STRUCTURE; DIELECTRIC CONSTANT; DIMERIZATION; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; OLIGOMERIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SCORING SYSTEM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; ANIMAL; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; PROTEIN MULTIMERIZATION;

ANIMALS; COMPUTATIONAL BIOLOGY; MODELS, MOLECULAR; PROTEIN MULTIMERIZATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84930983678     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666141013102515     Document Type: Article

References (95)

1. [I] Ellis, C. The state of GPCR research in 2004. Nat. Rev. Drug Discov., 2004, 3(7), 575, 575-577, 626.
2. [2] Muller, G. Towards 3D structures of G protein-coupled receptors: a multidisciplinary approach. Curr. Med. Chem., 2000, 7(9), 861-888.
3. [3] Pin, J.P.; Neubig, R.; Bouvier, M.; Devi, L.; Filizola, M.; Javitch, J.A.; Lohse, M.J.; Milligan, G.; Palczewski, K.; Parmentier, M.; Spedding, M. International union of basic and clinical pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol. Rev., 2007, 59(1), 5-13.
4. [4] Ferre, S.; Baler, R.; Bouvier, M.; Caron, M.G.; Devi, L.A.; Durroux, T.; Fuxe, K.; George, S.R.; Javitch, J.A.; Lohse, M.J.; Mackie, K.; Milligan, G.; Pfleger, K.D.; Pin, J.P.; Volkow, N.D.; Waldhoer, M.; Woods, A.S.; Franco, R. Building a new conceptual framework for receptor heteromers. Nat. Chem. Biol., 2009, 5(3), 131-134.
5. [5] Filizola, M. Advances in experimental medicine and biology: G protein-coupled receptors - modeling and simulation, Part II GPCRs in motion: insights from simulations. 2014, 796, 37-125.
6. [6] Angers, S.; Salahpour, A.; Joly, E.; Hilairet, S.; Chelsky, D.; Dennis, M.; Bouvier, M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. USA, 2000, 97(7), 3684-3689.
7. [7] Angers, S.; Salahpour, A.; Bouvier, M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol., 2002, 42, 409-435.
8. [8] Cheng, Z.J.; Miller, L.J. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J. Biol. Chem., 2001, 276(51), 48040-48047.
9. [9] McVey, M.; Ramsay, D.; Kellett, E.; Rees, S.; Wilson, S.; Pope, A.J.; Milligan, G. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J. Biol. Chem., 2001, 276(17), 14092-14099.
10. [10] Dinger, M.C.; Bader, J.E.; Kobor, A.D.; Kretzschmar, A.K.; Beck-Sickinger, A.G. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J. Biol. Chem., 2003, 278(12), 10562-10571.
11. 11[] Guo, W.; Shi, L.; Filizola, M.; Weinstein, H.; Javitch, J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc. Natl. Acad. Sci. USA, 2005, 102(48), 17495-17500.
12. [12] Schertler, G.F.; Hargrave, P.A. Projection structure of frog rhodopsin in two crystal forms. Proc. Natl. Acad. Sci. USA, 1995, 92(25), 11578-11582.
13. [13] Davies, A.; Schertler, G.F.; Gowen, B.E.; Saibil, H.R. Projection structure of an invertebrate rhodopsin. J. Struct. Biol., 1996, 117(1), 36-44.
14. [14] Davies, A.; Gowen, B.E.; Krebs, A.M.; Schertler, G.F.; Saibil, H.R. Three-dimensional structure of an invertebrate rhodopsin and basis for ordered alignment in the photoreceptor membrane. J. Mol. Biol., 2001, 314(3), 455-463.
15. [15] Fotiadis, D.; Liang, Y.; Filipek, S.; Saperstein, D.A.; Engel, A.; Palczewski, K. Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature, 2003, 421(6919), 127-128.
16. [16] Fotiadis, D.; Liang, Y.; Filipek, S.; Saperstein, D.A.; Engel, A.; Palczewski, K. The G protein-coupled receptor rhodopsin in the native membrane. FEBS. Lett., 2004, 564(3), 281-288.
17. [17] Liang, Y.; Fotiadis, D.; Filipek, S.; Saperstein, D.A.; Palczewski, K.; Engel, A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem., 2003, 278(24), 21655-21662.
18. [18] Herrick-Davis, K.; Grinde, E.; Cowan, A.; Mazurkiewicz, J.E. Fluorescence correlation spectroscopy analysis of serotonin, adrenergic, muscarinic, and dopamine receptor dimerization: the oligomer number puzzle. Mol. Pharmacol., 2013, 84(4), 630-642.
19. [19] Kasai, R.S.; Kusumi, A. Single-molecule imaging revealed dynamic GPCR dimerization. Curr. Opin. Cell Biol., 2014, 27, 78-86.
20. [20] Park, J.H.; Scheerer, P.; Hofmann, K.P.; Choe, H.W.; Ernst, O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nat., 2008, 454(7201), 183-187.
21. [21] Wu, B.; Chien, E.Y.; Mol, C.D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F.C.; Hamel, D.J.; Kuhn, P.; Handel, T.M.; Cherezov, V.; Stevens, R.C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science, 2010, 330(6007), 1066-1071.
22. [22] Choe, H.W.; Kim, Y.J.; Park, J.H.; Morizumi, T.; Pai, E.F.; Krauss, N.; Hofmann, K.P.; Scheerer, P.; Ernst, O.P. Crystal structure of metarhodopsin II. Nature, 2011, 471 (7340), 651-655.
23. [23] Manglik, A.; Kruse, A.C.; Kobilka, T.S.; Thian, F.S.; Mathiesen, J.M.; Sunahara, R.K.; Pardo, L.; Weis, W.I.; Kobilka, B.K.; Granier, S. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature, 2012, 485(7398), 321-326.
24. [24] Wu, H.; Wacker, D.; Mileni, M.; Katritch, V.; Han, G.W.; Vardy, E.; Liu, W.; Thompson, A.A.; Huang, X.P.; Carroll, F.I.; Mascarella, S.W.; Westkaemper, R.B.; Mosier, P.D.; Roth, B.L.; Cherezov, V.; Stevens, R.C. Structure of the human kappa-opioid receptor in complex with JDTic. Nature, 2012, 485(7398), 327-332.
25. [25] Huang, J.; Chen, S.; Zhang, J.J.; Huang, X.Y. Crystal structure of oligomeric beta1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat. Struct. Mol. Biol., 2013, 20(4), 419-425.
26. [26] Simpson, L.M.; Taddese, B.; Wall, I.D.; Reynolds, C.A. Bioinformatics and molecular modelling approaches to GPCR oligomerization. Curr. Opin. Pharmacol., 2010, 10(1), 30-37.
27. [27] Selent, J.; Kaczor, A.A. Oligomerization of G protein-coupled receptors: computational methods. Curr. Med. Chem., 2011, 18(30), 4588-4605.
28. [28] Conn, P.M. Receptor-Receptor interactions. Chapter 4 Simulating G Protein-coupled receptors in native-like membranes: from monomers to oligomers. Methods Cell Biol., 2013, 117, 63-90.
29. [29] Salom, D.; Lodowski, D.T.; Stenkamp, R.E.; Le, T.I.; Golczak, M.; Jastrzebska, B.; Harris, T.; Ballesteros, J.A.; Palczewski, K. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc. Natl. Acad. Sci. USA, 2006, 103(44), 16123-16128.
30. [30] Scheerer, P.; Park, J.H.; Hildebrand, P.W.; Kim, Y.J.; Krauss, N.; Choe, H.W.; Hofmann, K.P.; Ernst, O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature, 2008, 455(7212), 497-502.
31. [31] Periole, X.; Knepp, A.M.; Sakmar, T.P.; Marrink, S.J.; Huber, T. Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers. J. Am. Chem. Soc., 2012, 134(26), 10959-10965.
32. [32] Murakami, M.; Kouyama, T. Crystal structure of squid rhodopsin. Nature, 2008, 453(7193), 363-367.
33. [33] Shimamura, T.; Shiroishi, M.; Weyand, S.; Tsujimoto, H.; Winter, G.; Katritch, V.; Abagyan, R.; Cherezov, V.; Liu, W.; Han, G.W.; Kobayashi, T.; Stevens, R.C.; Iwata, S. Structure of the human histamine H1 receptor complex with doxepin. Nature, 2011, 475(7354), 65-70.
34. [34] Lichtarge, O.; Bourne, H.R.; Cohen, F.E. An evolutionary trace method defines binding surfaces common to protein families. J. Mol. Biol., 1996, 257(2), 342-358.
35. [35] Gobel, U.; Sander, C.; Schneider, R.; Valencia, A. Correlated mutations and residue contacts in proteins. Proteins, 1994, 18(4), 309-317.
36. [36] Gouldson, P.R.; Dean, M.K.; Snell, C.R.; Bywater, R.P.; Gkoutos, G.; Reynolds, C.A. Lipid-facing correlated mutations and dimerization in G-protein coupled receptors. Prot. Eng., 2001, 14(10), 759-767.
37. [37] Soyer, O.S.; Dimmic, M.W.; Neubig, R.R.; Goldstein, R.A. Dimerization in aminergic G-protein-coupled receptors: Application of a hidden-site class model of evolution. Biochem., 2003, 42(49), 14522-14531.
38. [38] Filizola, M.; Weinstein, H. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics. FEBS. J., 2005, 272(12), 2926-2938.
39. [39] Vohra, S.; Chintapalli, S.V.; Illingworth, C.J.; Reeves, P.J.; Mullineaux, P.M.; Clark, H.S.; Dean, M.K.; Upton, G.J.; Reynolds, C.A. Computational studies of Family A and Family B GPCRs. Biochem. Soc. Trans., 2007, 35(4), 749-754.
40. [40] Reggio, P.H. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS. J., 2006, 8(2), E322-E336.
41. [41] Vanni, S.; Rothlisberger, U. A closer look into G protein coupled receptor activation: X-ray crystallography and long-scale molecular dynamics simulations. Curr. Med. Chem., 2012, 19(8), 1135-1145.
42. [42] Gutierrez-de-Teran, H.; Bello, X.; Rodriguez, D. Characterization of the dynamic events of GPCRs by automated computational simulations. Biochem. Soc. Trans., 2013, 41(1), 205-212.
43. [43] Neri, M.; Vanni, S.; Tavernelli, I.; Rothlisberger, U. Role of aggregation in rhodopsin signal transduction. Biochem., 2010, 49(23), 4827-4832.
44. [44] Rodriguez, D.; Gutierrez-de-Teran, H. Characterization of the homodimerization interface and functional hotspots of the CXCR4 chemokine receptor. Proteins, 2012, 80(8), 1919-1928.
45. [45] Zhu, L.; Zhao, Q.; Wu, B. Structure-based studies of chemokine receptors. Curr. Opin. Struct. Biol., 2013, 23(4), 539-546.
46. [46] Gonzalez-Maeso, J.; Ang, R.L.; Yuen, T.; Chan, P.; Weisstaub, N.V.; Lopez-Gimenez, J.F.; Zhou, M.; Okawa, Y.; Callado, L.F.; Milligan, G.; Gingrich, J.A.; Filizola, M.; Meana, J.J.; Sealfon, S.C. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature, 2008, 452(7183), 93-97.
47. [47] Fribourg, M.; Moreno, J.L.; Holloway, T.; Provasi, D.; Baki, L.; Mahajan, R.; Park, G.; Adney, S.K.; Hatcher, C.; Eltit, J.M.; Ruta, J.D.; Albizu, L.; Li, Z.; Umali, A.; Shim, J.; Fabiato, A.; MacKerell, A.D.; Brezina, V.; Sealfon, S.C.; Filizola, M.; Gonzalez-Maeso, J.; Logothetis, D.E. Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell, 2011, 147(5), 1011-1023.
48. [48] Bruno, A.; Guadix, A.E.; Costantino, G. Molecular dynamics simulation of the heterodimeric mGluR2/5HT(2A) complex. An atomistic resolution study of a potential new target in psychiatric conditions. J. Chem. Inf. Model., 2009, 49(6), 1602-1616.
49. [49] Mondal, S.; Johnston, J.M.; Wang, H.; Khelashvili, G.; Filizola, M.; Weinstein, H. Membrane driven spatial organization of GPCRs. Sci. Rep., 2013, 3, 2909.
50. [50] Ghosh, A.; Sonavane, U.; Joshi, R. Multiscale modelling to understand the self-assembly mechanism of human beta2-adrenergic receptor in lipid bilayer. Comput. Biol. Chem., 2014, 48, 29-39.
51. [51] Prasanna, X.; Chattopadhyay, A.; Sengupta, D. Cholesterol modulates the dimer interface of the beta(2)-adrenergic receptor via cholesterol occupancy sites. Biophys. J., 2014, 106(6), 1290-1300.
52. [52] Soubias, O.; Gawrisch, K. The role of the lipid matrix for structure and function of the GPCR rhodopsin. Biochim. Biophys. Acta., 2012, 1818(2), 234-240.
53. [53] Yao, Z.; Kobilka, B. Using synthetic lipids to stabilize purified beta2 adrenoceptor in detergent micelles. Anal. Biochem., 2005, 343(2), 344-346.
54. [54] Paila, Y.D.; Jindal, E.; Goswami, S.K.; Chattopadhyay, A. Cholesterol depletion enhances adrenergic signaling in cardiac myocytes. Biochim. Biophys. Acta., 2011, 1808(1), 461-465.
55. [55] Pontier, S.M.; Percherancier, Y.; Galandrin, S.; Breit, A.; Gales, C.; Bouvier, M. Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J. Biol. Chem., 2008, 283(36), 24659-24672.
56. [56] Pucadyil, T.J.; Chattopadhyay, A. Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus. Biochim. Biophys. Acta, 2004, 1663(1-2), 188-200.
57. [57] Pucadyil, T.J.; Chattopadhyay, A. Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin(1A) receptor in the plasma membrane of living cells. Biochim. Biophys. Acta, 2007, 1768(3), 655-668.
58. [58] Saxena, R.; Chattopadhyay, A. Membrane cholesterol stabilizes the human serotonin(1A) receptor. Biochim. Biophys. Acta, 2012, 1818(12), 2936-2942.
59. [59] Jafurulla, M.; Chattopadhyay, A. Membrane lipids in the function of serotonin and adrenergic receptors. Curr. Med. Chem., 2013, 20(1), 47-55.
60. [60] Oates, J.; Watts, A. Uncovering the intimate relationship between lipids, cholesterol and GPCR activation. Curr. Opin. Struct. Biol., 2011, 21(6), 802-807.
61. [61] Paila, Y.D.; Chattopadhyay, A. Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell. Biochem., 2010, 51, 439-466.
62. [62] Lee, J.Y.; Lyman, E. Predictions for cholesterol interaction sites on the A2A adenosine receptor. J. Am. Chem. Soc., 2012, 134(40), 16512-16515.
63. [63] Sengupta, D.; Chattopadhyay, A. Identification of cholesterol binding sites in the serotonin1A receptor. J. Phys. Chem. B., 2012, 116(43), 12991-12996.
64. [64] Cang, X.; Du, Y.; Mao, Y.; Wang, Y.; Yang, H.; Jiang, H. Mapping the functional binding sites of cholesterol in beta2-adrenergic receptor by long-time molecular dynamics simulations. J. Phys. Chem. B., 2013, 117(4), 1085-1094.
65. [65] Provasi, D.; Johnston, J.M.; Filizola, M. Lessons from free energy simulations of delta-opioid receptor homodimers involving the fourth transmembrane helix. Biochem., 2010, 49(31), 6771-6776.
66. [66] Johnston, J.M.; Aburi, M.; Provasi, D.; Bortolato, A.; Urizar, E.; Lambert, N.A.; Javitch, J.A.; Filizola, M. Making structural sense of dimerization interfaces of delta opioid receptor homodimers. Biochem., 2011, 50(10), 1682-1690.
67. 67[] Johnston, J.M.; Wang, H.; Provasi, D.; Filizola, M. Assessing the relative stability of dimer interfaces in g protein-coupled receptors. PLoS. Comput. Biol., 2012, 8(8), e1002649.
68. [68] Kaczor, A.A.; Selent J.; Sanz, F.; Pastor, M. Modeling complexes of transmembrane proteins: systematic analysis of protein-protein docking tools. Mol. Inf., 2013, 32, 717-733.
69. [69] Casciari, D.; Seeber, M.; Fanelli, F. Quaternary structure predictions of transmembrane proteins starting from the monomer: a docking-based approach. BMC. Bioinfor., 2006, 7, 340.
70. [70] Fanelli, F. Dimerization of the lutropin receptor: insights from computational modeling. Mol. Cell Endocrinol., 2007, 260-262, 59-64.
71. [71] Casciari, D.; Dell'Orco, D.; Fanelli, F. Homodimerization of neurotensin 1 receptor involves helices 1, 2, and 4: Insights from quaternary structure predictions and dimerization free energy estimations. J. Chem. Inf. Model., 2008, 48(8), 1669-1678.
72. [72] Fanelli, F.; Felline, A. Dimerization and ligand binding affect the structure network of A(2A) adenosine receptor. Biochim. Biophys. Acta., 2011, 1808(5), 1256-1266.
73. [73] Fanelli, F.; Mauri, M.; Capra, V.; Raimondi, F.; Guzzi, F.; Ambrosio, M.; Rovati, G.E.; Parenti, M. Light on the structure of thromboxane A(2)receptor heterodimers. Cell Mol. Life Sci., 2011, 68(18), 3109-3120.
74. [74] O'Dowd, B.F.; Nguyen, T.; Ji, X.; George, S.R. D5 dopamine receptor carboxyl tail involved in D5-D2 heteromer formation. Biochem. Biophys. Res. Commun., 2013, 431(3), 586-589.
75. [75] Navarro, G.; Ferre, S.; Cordomi, A.; Moreno, E.; Mallol, J.; Casado, V.; Cortes, A.; Hoffmann, H.; Ortiz, J.; Canela, E.I.; Lluis, C.; Pardo, L.; Franco, R.; Woods, A.S. Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. J. Biol. Chem., 2010, 285(35), 27346-27359.
76. [76] Rossky, P.J.; Doll, J.D.; Friedman, H.L. Brownian dynamics as smart Monte Carlo simulation. J. Chem. Physics, 1978, 69(10), 14628-14633.
77. [77] Ouporov, I.V.; Knull, H.R.; Thomasson, K.A. Brownian dynamics simulations of interactions between aldolase and G- or F-actin. Biophys. J., 1999, 76(1 Pt 1), 17-27.
78. [78] Pearson, D.C.; Gross, E.L. Brownian dynamics study of the interaction between plastocyanin and cytochrome f. Biophys. J., 1998, 75(6), 2698-2711.
79. [79] Lowe, S.L.; Adrian, C.; Ouporov, I.V.; Waingeh, V.F.; Thomasson, K.A. Brownian dynamics simulations of glycolytic enzyme subsets with F-actin. Biopolym., 2003, 70(4), 456-470.
80. [80] Motiejunas, D.; Gabdoulline, R.; Wang, T.; Feldman-Salit, A.; Johann, T.; Winn, P.J.; Wade, R.C. Protein-protein docking by simulating the process of association subject to biochemical constraints. Proteins, 2008, 71(4), 1955-1969.
81. [81] Ouporov, I.V.; Knull, H.R.; Huber, A.; Thomasson, K.A. Brownian dynamics simulations of aldolase binding glyceraldehyde 3- phosphate dehydrogenase and the possibility of substrate channeling. Biophys. J., 2001, 80(6), 2527-2535.
82. [82] Elcock, A.H.; Sept, D.; McCammon, J.A. Computer simulation of protein-protein interactions. J. Physical Chem. B., 2001, 105(8), 1504-1518.
83. [83] Haddadian, E.J.; Gross, E.L. Brownian dynamics study of cytochrome f interactions with cytochrome c6 and plastocyanin in Chlamydomonas reinhardtii plastocyanin, and cytochrome c6 mutants. Biophys. J., 2005, 88(3), 2323-2339.
84. [84] Cui, M.; Shen, J.; Briggs, J.M.; Luo, X.; Tan, X.; Jiang, H.; Chen, K.; Ji, R. Brownian dynamics simulations of interaction between scorpion toxin Lq2 and potassium ion channel. Biophys. J., 2001, 80(4), 1659-1669.
85. [85] Cui, M.; Shen, J.; Briggs, J.M.; Fu, W.; Wu, J.; Zhang, Y.; Luo, X.; Chi, Z.; Ji, R.; Jiang, H.; Chen, K. Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channels. J. Mol. Biol., 2002, 318(2), 417-428.
86. [86] Yu, L.; Sun, C.; Song, D.; Shen, J.; Xu, N.; Gunasekera, A.; Hajduk, P.J.; Olejniczak, E.T. Nuclear magnetic resonance structural studies of a potassium channel-charybdotoxin complex. Biochemistry, 2005, 44(48), 15834-15841.
87. [87] Cui, M.; Mezei, M.; Osman, R. Prediction of protein loop structures using a local move Monte Carlo approach and a grid-based force field. Prot. Eng. Des. Sel., 2008, 21(12), 729-735.
88. 88[] Meng, X.Y.; Zhang, H.X.; Mezei, M.; Cui, M. Predicting protein interactions by Brownian Dynamics simulations. J. Biomed. Biotechnol., 2012, 2012, Article ID 121034.
89. [89] Cui, M.; Mezei, M.; Osman, R. Modeling dimerizations of transmembrane proteins using Brownian dynamics simulations. J. Comput. Aided Mol. Des., 2008, 22(8), 553-561.
90. [90] Rohl, C.A.; Strauss, C.E.; Misura, K.M.; Baker, D. Protein structure prediction using Rosetta. Method Enzymol., 2004, 383, 66-93.
91. [91] Heldin, C.H. Dimerization of cell surface receptors in signal transduction. Cell, 1995, 80(2), 213-223.
92. [92] Milligan, G. Oligomerisation of G-protein-coupled receptors. J. Cell Sci., 2001, 114(7), 1265-1271.
93. [93] Rios, C.D.; Jordan, B.A.; Gomes, I.; Devi, L.A. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol. Ther., 2001, 92(2-3), 71-87.
94. [94] George, S.R.; O'Dowd, B.F.; Lee, S.P. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov., 2002, 1(10), 808-820.
95. [95] Cherezov, V.; Rosenbaum, D.M.; Hanson, M.A.; Rasmussen, S.G.; Thian, F.S.; Kobilka, T.S.; Choi, H.J.; Kuhn, P.; Weis, W.I.; Kobilka, B.K.; Stevens, R.C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science, 2007, 318(5854), 1258-1265.